C ARDIAC R ESYNCHRONIZATION T HERAPY (CRT) D EVICES BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
PRICE: US$2500 NO. OF PAGES: 476
TABLES/CHARTS: 103 REPORT CODE: ARMMR141N.1
PUBLICATION: JUNE 2014
www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
SEGMENTATION - By TYPE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P)
CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES BRICSS MARKET WATCH, 2012-2018 BRICSS Cardiac Resynchronization Therapy (CRT) Devices market value is expected to reach US$455 million by 2016, primarily supported by the product types - Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Cardiac Resynchronization Pacemakers (CRT-P). China accounts for nearly 25% of the market share and “Getting the Most from Our Research India claims more than 23%. In terms of CAGR, China Analysis” is the fastest growing region while India and South Korea are just behind. Among the product types, Cardiac Resynchronization Therapy Defibrillator (CRT-D) accounts more nearly half of the market value while Cardiac Resynchronization Pacemakers (CRT-P) segments add up to the remaining half. Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET SHARE BY TYPE - 2015-%
For more information on this report publication, please reach us at: sales@axisresearchmind.com
2
www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
REPORT FOCUS The report ‘Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report focuses on the current market trends, estimates and forecasts for the period 2012-2018. More than 727 market players are identified in cardiovascular devices industry out of which 122 key “Learn High Potential Market Dynamics companies that project improved market for Strategic Business Planning” activities in the near future are profiled. The report consists of 103 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
KEY COMPANIES PROFILED ABBOTT VASCULAR DEVICES, ACCELLENT, INC., AEROTEL MEDICAL SYSTEMS, LTD., ANGIODYNAMICS, INC., ASAHI INTECC CO., LTD., ASAHI KASEI CORPORATION, BERLIN HEART GMBH, BIOHEART, INC., BIOSENSORS INTERNATIONAL GROUP, LTD., BIOTRONIK GMBH & CO. KG., BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., CAMBRIDGE HEART, INC., CARDIOCOMM SOLUTIONS, INC., CARDIOROBOTICS, INC., COOK GROUP INCORPORATED, DRÄGER MEDICAL AG & CO. KG, ESAOTE S.P.A, FUDAN UNIVERSITY ZHONGSHAN HOSPITAL, GE HEALTHCARE, HEARTWARE LTD., INDRAPRASTHA APOLLO HOSPITAL, ITGI MEDICAL LTD., MEDTRONIC, INC., MERIT MEDICAL SYSTEMS, INC., MOLECULAR DEVICES, LLC, NIHON KOHDEN CORPORATION, SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD., SORIN GROUP USA, INC., SPECTRANETICS INTERNATIONAL B.V, ST. JUDE MEDICAL, USCOME LIMITED and many more…
For more information on this report publication, please reach us at: sales@axisresearchmind.com
3
www.axisresearchmind.com | Copyright Š 2014 | All Rights Reserved
CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
GEOGRAPHIC COVERAGE The region-wise distribution consists of Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea) analyzed individually.
TO PURCHASE THIS REPORT, FOLLOW BELOW LINK: Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
For more information on this report publication, please reach us at: sales@axisresearchmind.com
4